baber/WOPTO huggingface dataset:
Patent CA-2660108-A1 (CA)
Inventor: CHESNE PHILIPPE
IPC: G01C23/00
Filed: 2007-07-18
Abstract: The invention relates to a system comprising two combined instruments (ICS1, ICS2) mounted on board an aircraft, and means (10) of communication between the two combined instruments (ICS1, ICS2), each combined instrument (ICS1, ICS2) comprising autonomous means (101, 111, 141, 151; 102, 112, 142, 152) for determining the flight parameters of the aircraft and display means (131, 132) for displaying either flight parameters or navigation parameters of the aircraft. The system furthermore comprises a selection module (121, 122) making it possible to choose, from among the sensors (101, 111; 102, 112) of the two combined instruments (ICS1, ICS2), those adopted for determining the flight parameters. as a function of their availability and in displaying on the display means (131, 132) of either of the combined instruments (ICS1, ICS2) or of both the combined instruments (ICS1, ICS2) the flight parameters determined. The invention also relates to a method using the system described above.
Patent CA-2660377-A1 (CA)
Title: Quinolinone derivatives
Inventor: SURLERAUX DOMINIQUE LOUIS NESTOR GHISLAIN
IPC: A61K31/4375
Filed: 2007-09-28
Abstract: HIV inhibitory compounds of formula (I) including the stereoisomeric forms thereof, the pharmaceutically acceptable salts, and pharmaceutically acceptable solvates thereof; wherein R1 is cyano; R2 is H, C1-6alkyl, trifluoromethyl, amino, mono- or di-C1-6alkylamino, C1-6alkylamino wherein the C1-6alkyl group can be substituted; X1 is CH or N; R3 is phenyl or pyridyl, each unsubstituted or substituted; R4 is H, C1-6alkyl, (C1-6alkylcarbonyla mino)C1-6alkyl-, Ar, potionally substituted thienyl, furanyl, pyridyl, pyrimidyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, triazo lyl, oxazolyl, thiazolyl, halo, trifluoromethyl, hydroxy, C1-6alkyloxy, -OPO(OH)2, amino, aminocarbonyl, cyano, -Y1-R6, -Y1-Alk-R6, or -Y1-Alk-Y2-R7; R5 is H, halo, hydroxy or C1-6alkyloxy; or R4 and R5 form -O-CH2-O-; Y1 is O or NR8; Y2 is O or NR9; Alk is bivalent C1-6alkyl; R6 is pyrrolidinyl, piperidinyl, morpho linyl, piperazinyl, 4-C1 -6alkylpiperazinyl, 4-(C1-6alkylcarbonyl)piperazinyl, pyridyl, or imidazolyl; R7 is H, C1-6alkyl, hydroxyC1 -6alkyl, C1 -6alkylcarbonyl; R8 and R9 are H or C1-6alkyl; Ar is optionally substituted phenyl; pharmaceut ical compositions comprising the above compounds (I) as active ingredient.
Patent CA-2661810-A1 (CA)
Title: Perforated skin structure for laminar-flow systems
Inventor: BERTOLOTTI FABIO P
IPC: B64C1/00
Filed: 2003-04-17
Abstract: The outer skin (100) of an aerodynamic body (40) has perforations (200) arranged in particular patterns in respective spanwise extending groups or bundles (250). Each perforation is preferably a micro-slot with a length of 100 to 3000 µm and a width of 50 to 250 µm. Air is sucked through the micro-slots from the boundary layer flowing over the outer skin, to achieve boundary layer control. In each bundle, the pattern, size, orientation, and other parameters of the micro-slots are designed to achieve mutual destructive interference of flow disturbances arising due to the suction, to minimize the excitation of flow instabilities in the boundary layer. Particularly, the spatial spectrum of the perforation pattern of a given bundle is essentially absent of significant energy at predetermined wavelengths of predetermined flow instabilities that otherwise appear in the boundary layer air flow. The aerodynamic body further includes supporting ribs (300) extending parallel to the perforation bundles (250) and a perforated inner plate (400) providing a throttling control of the suction flow through groups of the bundles.
Patent CA-2663972-A1 (CA)
Title: A wiring assembly for an appliance
Inventor: WATKINS DEREK LEE
IPC: F24C15/02
Filed: 2009-04-24
Abstract: A wiring assembly for an appliance is disclosed. The appliance has a main body and a door movably attached to the main body. The wiring assembly includes a base attachable to the door and having a first end and a second end; a slide slidably mounted on the base so that the slide is moveable between a first position where the slide is adjacent to the first end and a second position where the slide is adjacent to the second end; a tensioning or biasing member engaging the slide with the base and biasing the slide to the first position; and a cable assembly including a power/communication cable attachable to the main body and connected to the slide. An appliance incorporating such a wiring assembly is also disclosed.
Patent CA-2664383-A1 (CA)
Title: Micrornas differentially expressed in pancreatic diseases and uses thereof
Inventor: SZAFRANSKA ANNA E
IPC: C12N15/113
Filed: 2007-09-19
Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
Patent CA-2665343-A1 (CA)
Title: Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
Inventor: FELDMANN GEORG
IPC: A61K47/30
Filed: 2007-10-05
Abstract: Polymeric nanoparticles with a hydrophobic core and a hydrophilic shell are formed from: 1) N-isopropyl acrylamide (NIPAAM), at a molar ratio of about 50% to about 90%, and preferably 60% for specific delivery routes such as oral or parenteral; either water-soluble vinyl derivatives like vinylpyrolidone (VP) or vinyl acetate (VA), or water insoluble vinyl derivatives like methyl methacrylate (MMA) or styrene (ST), at a molar ratio of about 10% to about 30%;, and acrylic acid (AA), at a molar ratio of about 10% to about 30%. The formed nanoparticles may be optionally surface functional using reactive groups present in AA, including PEGylation, or conjugation of moieties such as chemotherapeutics, contrasting agents, antibodies, radionucleides, ligands, and sugars, for diagnostic, therapeutic, and imaging purposes. The polymeric nanoparticles are preferably dispersed in aqueous solutions. The polymeric nanoparticles incorporate one or more types of medicines or bioactive agents in the hydrophobic core; on occasion, the medicine or bioactive agent may be conjugated to the nanoparticle surface via reactive functional groups. The polymeric nanoparticles are capable of delivering the said medicines or bioactive agents through oral, parenteral, or topical routes. The polymeric nanoparticles allow poorly water soluble medicines or bioactive agents, or those with poor oral bioavailability, to be formulated in an aqueous solution, and enable their convenient delivery into the systemic circulation.
Patent CA-2665374-A1 (CA)
Inventor: TOSO KENNETH E
IPC: A61F2/00
Filed: 2007-10-03
Abstract: The invention generally relates to surgically implantable supportive slings. More specifically, in various embodiments, the invention is directed to sling assemblies for pelvic floor repair that utilize one or more materials, attached without a mechanical fixation device, and related methods of use and fabrication.
Patent CA-2668194-A1 (CA)
Inventor: FALLIN T WADE
IPC: A61B17/88
Filed: 2007-11-05
Abstract: A system for accessing a spine from a curved postero-lateral approach may include a curved cannula positioned along a curved path from an opening in the skin to a location proximate the spine. A targeting post may be inserted adjacent the spine to determine the location. A peritoneal retractor and a guide member may be first inserted to establish the path between the tissues and fascia, and one or more intermediate cannulas may be temporarily inserted over the guide member to dilate the tissues prior to insertion of the main cannula. An interbody device may be implanted in an intervertebral space through the cannula. An endoscope may be inserted through the targeting post or the cannula. The system may include instruments with shafts which are flexible or are curved to match the curve of the curved cannula, including a rongeur, curette, rasp, distractor, trial implant, probe, tamp, and implant inserter.
Patent CA-2668525-A1 (CA)
Inventor: FARNSWORTH ANDREW
IPC: H04W52/02
Filed: 2009-06-09
Abstract: A method and device for transmitting a sequence of messages from a handheld telecommunications device to a telecommunications network is described, the sequence of messages comprising a plurality of messages to be transmitted at specified times. The method comprises transmitting a message of the sequence of messages and turning off at least one of the transmitter and receiver of the device after transmission of at least one of the messages in the sequence of messages. The method has particular application to messages that terminate a radio connection between the device and the network, such as RRC Connection Release Complete messages in a UMTS system.
Patent CA-2668872-A1 (CA)
Title: Melt-spun elastoester multifilament yarns
Inventor: SUNKARA HARI BABU
IPC: D01F6/86
Filed: 2007-12-05
Abstract: This invention relates to a method of melt-spinning a polyether ester thermoplastic elastomer under commercially viable conditions to produce an elastoester multifilament yarn, wherein the polyether ester thermoplastic elastomer is a polytrimethylene ether ester comprising a polytrimethylene ether dicarboxylate ester soft segment and hard segment selected from a trimethylene dicarboxylate ester and/or a tetramethylene dicarboxylate ester hard segment.
Patent CA-2670991-A1 (CA)
Inventor: AKEMI HITOSHI
IPC: A61P25/28
Filed: 2007-11-30
Abstract: [PROBLEMS] To provide a stable percutaneous absorption preparation for percutaneous absorption of donepezil or hydrochloride salt thereof that even at pasting, suppresses any drop of cohesion force of pressure sensitive adhesive layer and that also suppresses any adhesive residue by cohesion failure at stripping off. [MEANS FOR SOLVING PROBLEMS] The percutaneous absorption preparation is characterized by having a pressure sensitive adhesive layer containing 2-[(1-benzyl-4-piperidinyl)methyl]-5,6-dimethoxyindan- 1-one and/or its hydrochloride salt and a metal chloride, the pressure sensitive adhesive layer being crosslinked.
Patent CA-2671158-A1 (CA)
Inventor: KUWABARA NAOKI
IPC: B60G7/00
Filed: 2009-07-06
Abstract: To provide a suspension arm of a vehicle that can be lighter in weight while the rigidity thereof is secured. A suspension arm of a vehicle includes: a pivot pipe swingably attached to a vehicle body frame; a pair of a front pipe and a rear pipe arranged side by side in a front-rear direction of a vehicle body, the pair of pipes having one end portions that are apart from each other in the front-rear direction of the vehicle body and connected to the pivot pipe, as well as having the other end portions that come closer to each other while extending toward an outer side of the vehicle body, so as to form a substantially triangular shape; and a joint attached to leading end portions, at the outer side of the vehicle body, of the pair of the front pipe and the rear pipe, and including a plate portion and a boss portion to which a knuckle is attached. The suspension arm further includes a substantially U shaped plate arranged at the other end portions of the pair of the front pipe and the rear pipe in a way to open toward the outer side of the vehicle body. In the suspension arm of a vehicle, the other end portions of the pair of the front pipe and the rear pipe are connected to an outer curved surface of the U shaped plate, and the plate portion of the joint is attached to the pair of the front pipe and the rear pipe in a way to cover the U shaped plate from above or below.
Patent CA-2672529-A1 (CA)
Inventor: MARSH CLIVE
IPC: A61K38/00
Filed: 2007-12-11
Abstract: The invention relates to a porous keratin construct material comprising keratin protein for use in wound healing applications. The porous keratin construct is capable of bio-absorbing into a wound to promote wound healing. The rate at which the construct bio-absorbs into the wound may be controlled altered by controlling the degree of disulfide cross-linking between the keratin proteins in the porous keratin construct. The invention is also related to a method of making the porous keratin construct.
Patent CA-2673262-A1 (CA)
Inventor: TANGY FREDERIC
IPC: C07K14/12
Filed: 2007-12-21
Abstract: The present invention relates to recombinant cells as well as to methods for the generation of non-segmented negative-sense single- stranded RNA viruses (NNV or mononegavirales) from cloned deoxyribonucleic acid (cDNA), especially from measles virus and in particular from attenuated strains such as those approved for vaccination, in particular from the attenuated Schwarz measles virus and various recombinant Schwarz measles-based viruses expressing heterologous sequences. Such rescued viruses can be used, after amplification, as vaccines for immunization against measles and/or against the heterologous peptides or proteins expressed.
Patent CA-2673759-A1 (CA)
Inventor: HUBOUD-PERON MAURICE
IPC: E01B3/04
Filed: 2007-12-12
Abstract: The saw (2) has a motor unit (3) for driving a cutting disc (6) e.g. abrasive disc, via a belt (5), where the disc is fixed on a disc holder (7). A hollow shaft (8) is fixed on a saw supporting and guiding device, where an axis of the shaft is parallel to an axis of the disc. The device has a vise fixed to a rail, and allows pivotment of the saw in a cutting disc plane. The shaft and the disc holder form a monoblock assembly (9) mounted on the motor unit with interposition of elastic studs.
Patent CA-2674547-A1 (CA)
Inventor: BANTA KEVIN D
IPC: H02J7/34
Filed: 2008-01-16
Abstract: Apparatuses, systems, and methods for providing, battery-backed power to movable partitions are disclosed. A power converter (210) generates a DC output (212) from an AC input (205). The DC output (212) may be selectively decoupled from an enabled DC output (216) such that the DC output (212) can be monitored for acceptable operation in-situ. The enabled DC output (216) may be selectively coupled to a battery output terminal (264). A charge current may be sensed between the enabled DC output (216) and the battery output (264) to control charging of the battery (260) with a pulse-width modulation operation by controlling the selective coupling of the enabled DC output (216) to the battery output (264). The enabled DC output (216) and the battery output (264) are coupled in a logical-or configuration to generate a supply output (296) providing current from the enabled DC output (216) and the battery (260). The supply output (296) may drive a movable partition controller and a motor configured for opening and closing a movable partition.
Patent CA-2674632-A1 (CA)
Title: Dual-functional nonfouling surfaces and materials
Inventor: JIANG SHAOYI
IPC: G01N31/22
Filed: 2007-12-31
Abstract: Dual-functional nonfouling surfaces and materials, methods for making dual- functional nonfouling surfaces and materials, and devices that include dual-functional nonfouling surfaces and materials. The dual-functional surfaces are nonfouling surfaces that resist non-specific protein adsorption and cell adhesion. The dual-functional surfaces and materials include covalently coupled biomolecules (e.g., target binding partners) that impart specific biological activity thereto. The surfaces and materials are useful in medical diagnostics, biomaterials and bioprocessing, tissue engineering, and drug delivery.
Patent CA-2677061-A1 (CA)
Inventor: KIKUCHI TSUKASA
IPC: A61P13/02
Filed: 2008-01-31
Abstract: Disclosed are: a benzylamine derivative typified by the formula below and a pharmaceutically acceptable acid addition salt thereof; a pharmaceutical agent comprising the derivative or the pharmaceutically acceptable acid addition salt thereof; and a therapeutic or prophylactic agent for frequent urination or urinary incontinence, which comprises the derivative or the pharmaceutically acceptable acid addition salt thereof. The benzylamine derivative and the pharmaceutically acceptable acid addition salt thereof have reduced adverse side effects compared to conventional compounds and high therapeutic effect on frequent urination or urinary incontinence. Therefore, the benzylamine derivative and the pharmaceutically acceptable acid addition salt thereof can be used as an excellent therapeutic or prophylactic agent for frequent urination or urinary incontinence.
Patent CA-2681583-A1 (CA)
Inventor: ASSANDRI FABIO
IPC: B01F23/10
Filed: 2008-03-19
Abstract: L'invention porte sur un dispositif de mélange de deux gaz/vapeurs (désignés ci-après comme <= les gaz >=). Le dispositif comporte a) une pluralité de tubes disposés en faisceau (1), dont la partie initiale est dotée d'une pluralité de trous latéraux (5); b) un premier système d'alimentation de l'un des deux gaz comprenant un premier corps tubulaire (6) situé sur le côté entrée des tubes; et c) un second système d'alimentation de l'autre gaz comprenant un second corps tubulaire (7) qui enveloppe le faisceau de tubes (1) et au moins une partie du premier corps tubulaire (6) d'une manière étanche aux gaz. Le dispositif précité est caractérisé en ce que d) le premier corps tubulaire (6) du premier système d'alimentation de l'un des gaz comporte une pluralité d'ailettes (8) qui permettent une distribution uniforme du gaz d'alimentation dans les tubes individuels.
Patent CA-2681595-A1 (CA)
Title: Compressor having a high pressure slide valve assembly
Inventor: PICOUET JEAN LOUIS
IPC: F04C28/12
Filed: 2008-03-25
Abstract: A compressor having a high pressure slide valve assembly is disclosed. Th e slide valve assembly includes: a volume slide valve mechanism, the mechani sm slidably movable to control compressor volume ratio and power input to th e compressor. The assembly also includes a capacity slide valve mechanism th at is in operational association with the volume slide valve mechanism, the capacity slide valve mechanism slidably movable to control compressor capaci ty. At least one of the volume slide valve mechanism and the capacity slide valve mechanism includes at least one groove or channel, and the at least on e groove or channel provides for lubrication to ensure relative movement bet ween the slide mechanisms in a high pressure environment. A method of contro lling compressor volume ratio, power input and capacity in a compressor oper ating in a high pressure environment is also disclosed.
Patent CA-2682727-A1 (CA)
Inventor: NAGASE TSUYOSHI
IPC: A61P33/00
Filed: 2008-03-27
Abstract: A compound represented by the general formula (I-a): (I-a) [wherein R1a and R2a each means hydrogen, lower cycloalkyl, lower alkyl, etc.; R3a means hydrogen, lower cycloalkyl, lower alkyl, etc.; R4a and R5a each means lower alkyl, lower cycloalkyl, etc. or R4a and R5a are bonded to each other to form lower cycloalkylidene; and R6a means lower alkyl, lower haloalkyl, etc.]. This compound functions as an LCE inhibitor and is useful as a therapeutic agent for various circulatory diseases, nervous diseases, metabolic diseases, reproductive diseases, digestive tract diseases, neoplasm, infectious diseases, etc.
Patent CA-2683516-A1 (CA)
Inventor: ZHANG KEWEI
IPC: C09K8/04
Filed: 2008-04-11
Abstract: A sand slurry composition and a method for making sand slurries are disclosed. The sand slurry composition is comprised of sand, an aqueous liquid and a chemical compound that renders the surface sand of hydrophobic. The method is comprised of rendering sand surface hydrophobic during or before making the slurry. This method and composition can find many applications in different industries, especially in various oil field applications.
Patent CA-2683677-A1 (CA)
Title: Method and system of ultrasound scatterer characterization
Inventor: YU FRANCOIS
IPC: A61B8/08
Filed: 2008-04-10
Abstract: A method for characterizing ultrasound scatterers in a medium comprising providing ultrasound data representing a region of interest comprising a plurality of scatterers in a medium, the plurality of scatterers including clusters of scatterer sub-units, the scatterers having a physical property value to be estimated and the scatterer sub-units having at least one known physical parameter value; modelling the ultrasound data using an at least second order function of a spatial organization parameter defining the spatial organization of the scatterers; and estimating the physical property value of the scatterers from the modelled ultrasound data and the at least one known physical parameter of the sub-units by a regression of the spatial organization parameter as a function of frequency. A system for characterizing ultrasound scatterers is also included.
Patent CA-2684591-A1 (CA)
Inventor: KNAPIKOVA JARMILA
IPC: A61P27/06
Filed: 2008-04-18
Abstract: Substituted sulphonamides having the general formula (I) and salts, hydrates and solvates thereof were prepared and described, wherein R1 isCO or SO2 and R2 is NH or O and where R represents linear or cyclic aliphatic chain and n represents number of linking aliphatic chain carbons (n can be 0, 1, 2 or 3), which are useful in the manufacture of the medicaments due to the carboanhydrase inhibition. These compounds are prepared by nucleophilic reaction of an amine with 4-sulfamoylbenzenesulphonyl chloride in the presence of triethylamine excess in tetrahydrofurane or in ether at temperature 0 to 20 °C. The compounds show an antiglaucomatic activity.
Patent CA-2686211-A1 (CA)
Inventor: NONG THOA
IPC: C12Q1/68
Filed: 2008-05-01
Abstract: The present invention relates to methods for screening for binding intera ctions using multiple sets of microparticles, wherein said set has the same identifiable characteristic and wherein one of more sets comprise subsets of microparticles and said subset presents at least one unique probe that acts as a binding partner for a target molecule in a biological sample. In parti cular, the invention provides for methods of detecting tissue -typing antige ns in donor tissue or recipient tissue using these multiple sets of micropar ticles.
Patent CA-2687063-A1 (CA)
Title: Aloe preparation for skin enhancement
Inventor: NEEDLEMAN ALVIN
IPC: A61K36/886
Filed: 2008-05-09
Abstract: Methods for providing skin enhancement and pain relief to an individual in need of treatment by administering to such an individual an effective amount of an immunostimulatory Aloe vera derived composition. Oral and topical methods and compositions are provided. Aloe vera derived immunostimulatory compositions and methods of producing such compositions are provided.
Patent CA-2688736-A1 (CA)
Title: Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
Inventor: FERRARI STEFANO
IPC: A61K38/47
Filed: 2008-04-09
Abstract: A composition comprising a content of a lysozyme and a content of a C-1/C-4 polysaccharide is useful in oral care, cosmetology and dermatology, contraception, urology and gynecology. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader quickly to ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the appended issued claims.
Patent CA-2689257-A1 (CA)
Title: Hearing aid system for establishing a conversation group
Inventor: RANK MIKE LIND
IPC: H04R25/00
Filed: 2008-06-13
Abstract: A hearing aid system adapted for establishing a conversation group with other hearing aid systems used by different users, said hearing aid system comprising a hearing aid (1, 2, 3, 4, 5) with an associated relay device (11, 12, 13, 14, 15). The relay device is (11, 12, 13, 14, 15) adapted for wireless communication (21, 22, 23, 24, 25) with said hearing aid and for wireless communication (31, 32, 33, 34, 35) with a second hearing aid system. The relay device (11, 12, 13, 14, 15) is also adapted for receiving and displaying information about said second hearing aid systems being available for participation in said conver- sation group, and it comprises means for selection of said other hearing aid systems for inclusion into the conversation group.